@uwmadisonchem.bsky.socialJoin us for an upcoming CHEMBIO Seminar featuring Professor Jason Gestwicki from the University of California, San Francisco.
We hope you’ll join us!
#UWMadison #UWChemistry #ChemicalBiology #CHEMBIO #ProteinScience #DrugDiscovery #Seminar
@medinadiscovery.bsky.socialDo you want to know more about Fundación MEDINA?
Book a B2B meeting through the BioJapan partnering platform: biojapan2026.jcdbizmatch.jp/en/Login
#DrugDiscovery #HighContentScreening #CellPainting #DiseaseModels #FundacionMEDINA
@diseaseatlas.bsky.socialThe best target question is often the one nobody has time to run. Disease Atlas by Euretos puts that depth within reach of the person asking: causal evidence, cell-type resolution, tractability and safety, in one session, into a rationale you can defend. #DrugDiscovery
@medchem1.bsky.social#AlzheimersResearch is challenging. AD involves a complex network of interconnected pathways, each worthy of exploration. Researchers continually innovate, collaborate, and persist in pursuit of a cure.
Together, we continue the climb, one step at a time.
@aging-us.bsky.socialAging is pleased to announce that we are a media partner of the 13th Aging Research & Drug Discovery Meeting (ARDD), taking place October 1–3 at Harvard University in Boston, MA.
🔗 Learn more:
https://bit.ly/3UfNcue
@fiosgenomics.bsky.socialLooking for a #bioinformatics provider to move your drug development program forward? 🔍
At Fios Genomics, we support #drugdiscovery and development, from early research to market submission.
Learn more at: https://www.fiosgenomics.com/bioinformatics-for-drug-discovery-and-development/
@longevitytech.bsky.socialAmorepacific deal puts therapeutic target discovery to work on skin aging – and Junevity sees scope for an ‘Ozempic moment’.
Link as first comment.
#longevity #skinaging #therapeutictarget #drugdiscovery #biotech
@oswaldosrm.bsky.socialAI-designed medicine is emerging as a promising approach to slow cellular aging. This article outlines recent research... A must-read for professionals in biotech, pharma, and longevity research: wix.to/7qHUsUB
#Biotech
#AIinHealthcare
#DrugDiscovery
#MedicalInnovation
#LongevityResearch
@xtalpi.bsky.socialKQTD-126 was designed to inhibit TRK activity in the gut while limiting systemic exposure.
The next question is whether that profile translates in patients. The IND submission brings us one step closer to finding out.
Full release: www.prnewswire.com/news-release...
@gltch.ioAI + protein analysis just sped up drug discovery! Baylor team found new molecular glues targeting blood cancers & autoimmune diseases. 🧪 #drugdiscovery
Source: https://phys.org/news/2026-09-ai-discovery-molecular-disease.html
@alvascience.bsky.socialalvaBuilder is featured in a new @cancers-mdpi.bsky.social
review on AI and big data in cancer drug discovery, among tools for iterative compound-library screening and generation.
Great to see our work included!
doi.org/10.3390/canc...
@promegauk.bsky.socialFree workshop Wed 14 Oct, 1.10pm BST at ELRIG Drug Discovery 2026: CRISPR Editing and HiBiT Protein Tagging for #EndogenousBiology
Move beyond overexpression to native expression levels. Speakers: Dr Joshua Sopp (Promega), Zofia Świątczak (EditCo) and Recursion
@mapjournals.bsky.social#Targetome
Respiratory chain complexes as programmable therapeutic nodes: beyond ATP bioenergetics toward context-dependent metabolic reprogramming.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0037
#RespiratoryChain #Mitochondria #MetabolicReprogramming #DrugDiscovery
@xtalpi.bsky.socialThe question now is whether KQTD-126 can make chronic intestinal pain easier to live with.
The candidate’s IND submission is a step toward finding out.
Full release: t.co/QJu4sfJzFC
@longevitytech.bsky.socialEnveda raised $311 million to push its AI-discovered medicines forward, including one aimed at life after GLP-1 drugs.
Link as first comment.
@remixtx.bsky.socialAt #DrugDiscoveryOnTarget, our CSO, Dominic Reynolds, will highlight REM-422, our first-in-class mRNA degrader targeting the MYB oncogene, and discuss how our REMaster® platform is enabling new approaches to previously undruggable RNA targets.
@nextlogic-ai.bsky.social🎨 New Post: AI's New Prescription: Reshaping the Future of Drug Discovery
#ai #drugdiscovery #pharmaceuticals #TechNews #GlobalMedia
👇 View Full Illustration:
https://nextlogic-ai.achlabo.com/en/ais-new-prescription-reshaping-the-future-of-drug-discovery/
@fiosgenomics.bsky.socialHave you heard about Target Triage❓
It makes drug target selection much easier, by collating all publicly available information about a target, in one place.
Want faster, smarter drug target selection? Enquire today!
www.fiosgenomics.com/service/target-triage
@movetheneedlenews.bsky.socialUK-based Basecamp Research raised $140M for AI drug discovery. They map global biodiversity to design new therapies.
Proving human safety remains the next major challenge.
@chemotargets.com#EuroQSAR2026 in Perugia about to kick off. Chemotargets’s booth is ready. Come visit us!
On display, our #D3_platform for generative drug design and #SafetyVista for translational safety.
